Tick octopamine receptor nucleic acid molecules
View Patent ↗The present invention relates to tick octopamine receptor nucleic acid molecules; to tick octopamine receptor proteins encoded by such nucleic acid molecules; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes inhibitory compounds, particularly those that specifically inhibit tick octopamine receptor activity, as well as the use of such compounds to treat animals.
1. An isolated nucleic acid molecule selected from the group consisting of:
(a) a nucleic acid molecule comprising a nucleic acid sequence that encodes a protein comprising SEQ ID NO:40; and
(b) a nucleic acid molecule comprising a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).
2. A recombinant molecule comprising a nucleic acid molecule as set forth in claim 1 operatively linked to a transcription control sequence.
3. A recombinant virus comprising a nucleic acid molecule as set forth in claim 1 .
4. An isolated, recombinant cell comprising a nucleic acid molecule as set forth in claim 1 .
5. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid sequence is selected from the group consisting of SEQ ID NO:39 and SEQ ID NO:41.
6. An isolated nucleic acid molecule consisting of a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence that encodes a polypeptide consisting of SEQ ID NO: 34, SEQ ID NO:37 or SEQ ID NO:40; and
(b) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).
7. The isolated nucleic acid molecule of claim 6 , wherein said nucleic acid sequence is selected from the group consisting of SEQ ID NO: 33, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 38, SEQ ID NO: 39 and SEQ ID NO: 41.